Contact Us
Click here to contact Felicity Thomas,editor.
November 6, 2013
Therapeutic promise Pazopanib shows therapeutic potential as treatment for AMD. Oral pazopanib — in a dose of 15 mg/d — is well tolerated and may improve mean best-corrected visual acuity (BCVA), central retinal lesion thickness, and central retinal thickness in as little as 1 month of treatment in some patients with age-related macular degeneration (AMD), according to recent study results. More...
Surgical results AS-OCT, IVCM effectively find, track epithelial downgrowth after penetrating keratoplasty Phacoemulsification done after trabeculectomy may significantly increase the rates of bleb failure in the following 12 months, but not at 24 months, according to a recently published study. More...
Imaging and diagnosis Laser speckle flowgraphy may be useful in identifying eyes with normal-tension glaucoma Waveform changes in optic nerve head (ONH) blood flow as measured by laser speckle flowgraphy maye useful in differentiating healthy eyes from those with normal-tension glaucoma (NTG), according to the authors of a recent study. More...
Choosing and using the AcrySof IQ ReSTOR IOL family
Customized options for individual patients.
Read more:
The Safety of anti-VEGF Therapy Under the microscope, in trials and in clinical practice. Read more:
